These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29660764)

  • 1. Prognostic utility of MELD-XI in adult congenital heart disease patients undergoing cardiac transplantation.
    Adams ED; Jackson NJ; Young T; DePasquale EC; Reardon LC
    Clin Transplant; 2018 Jun; 32(6):e13257. PubMed ID: 29660764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
    Konno R; Tatebe S; Sugimura K; Satoh K; Aoki T; Miura M; Suzuki H; Yamamoto S; Sato H; Terui Y; Miyata S; Adachi O; Kimura M; Saiki Y; Shimokawa H
    PLoS One; 2019; 14(11):e0225403. PubMed ID: 31743362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
    Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
    Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the United Network for Organ Sharing.
    Deo SV; Al-Kindi SG; Altarabsheh SE; Hang D; Kumar S; Ginwalla MB; ElAmm CA; Sareyyupoglu B; Medalion B; Oliveira GH; Park SJ
    J Heart Lung Transplant; 2016 Feb; 35(2):222-7. PubMed ID: 26527533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
    Amdani S; Simpson KE; Thrush P; Shih R; Simmonds J; Knecht K; Mogul DB; Hurley K; Koehl D; Cantor R; Naftel D; Kirklin JK; Daly KP
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1462-1473.e12. PubMed ID: 33745714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes.
    Loforte A; Fiorentino M; Gliozzi G; Mariani C; Folesani G; Suarez SM; Russo A; Masetti M; Potena L; Pacini D
    Transplant Proc; 2019 Nov; 51(9):2962-2966. PubMed ID: 31607616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
    Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term adult congenital heart disease survival after heart transplantation: A restricted mean survival time analysis.
    Dolgner SJ; Nguyen VP; Krieger EV; Stempien-Otero A; Dardas TF
    J Heart Lung Transplant; 2021 Jul; 40(7):698-706. PubMed ID: 33965332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease.
    Huntley GD; Danford DA; Menachem J; Kutty S; Cedars AM
    J Am Heart Assoc; 2021 Jul; 10(14):e020248. PubMed ID: 34238025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.
    Chokshi A; Cheema FH; Schaefle KJ; Jiang J; Collado E; Shahzad K; Khawaja T; Farr M; Takayama H; Naka Y; Mancini DM; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):591-600. PubMed ID: 22458996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation in the U.S.
    Alshawabkeh LI; Hu N; Carter KD; Opotowsky AR; Light-McGroary K; Cavanaugh JE; Bartlett HL
    J Am Coll Cardiol; 2016 Aug; 68(9):908-17. PubMed ID: 27561764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Center volume and post-transplant survival among adults with congenital heart disease.
    Menachem JN; Lindenfeld J; Schlendorf K; Shah AS; Bichell DP; Book W; Brinkley DM; Danter M; Frischhertz B; Keebler M; Kogon B; Mettler B; Rossano J; Sacks SB; Young T; Wigger M; Zalawadiya S
    J Heart Lung Transplant; 2018 Nov; 37(11):1351-1360. PubMed ID: 30174166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of pre and post-implant MELD-XI score on survival in children undergoing VAD implantation.
    Amdani S; Boyle GJ; Cantor RS; Conway J; Godown J; Kirklin JK; Koehl D; Lal AK; Law Y; Lorts A; Rosenthal DN
    J Heart Lung Transplant; 2021 Dec; 40(12):1614-1624. PubMed ID: 34598872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of the Model for End-Stage Liver Disease Score Excluding International Normalized Ratio One Year After Orthotopic Heart Transplantation.
    Szyguła-Jurkiewicz B; Zakliczyński M; Szczurek W; Nadziakiewicz P; Gąsior M; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1703-7. PubMed ID: 27496475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated heart transplant and combined heart-liver transplant in adult congenital heart disease patients: Insights from the united network of organ sharing.
    Bradley EA; Pinyoluksana KO; Moore-Clingenpeel M; Miao Y; Daniels C
    Int J Cardiol; 2017 Feb; 228():790-795. PubMed ID: 27888756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UNOS listing status-related changes in mechanical circulatory support utilization and outcomes in adult congenital heart disease patients.
    Zhou AL; Menachem JN; Danford DA; Kutty S; Cedars AM
    J Heart Lung Transplant; 2022 Jul; 41(7):889-895. PubMed ID: 35397877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adult congenital heart disease on survival and mortality after heart transplantation.
    Burchill LJ; Edwards LB; Dipchand AI; Stehlik J; Ross HJ
    J Heart Lung Transplant; 2014 Nov; 33(11):1157-63. PubMed ID: 25049065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.
    Chen Y; Liu YX; Seto WK; Wu MZ; Yu YJ; Lam YM; Au WK; Chan D; Sit KY; Ho LM; Tse HF; Yiu KH
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
    Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
    Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.